Article Versions Notes

Russo G, Barbieri MA, Sorbara EE, Cicala G, Franchina T, Santarpia M, Silvestris N, Spina E. Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database. Biomedicines. 2023; 11(8):2311. https://doi.org/10.3390/biomedicines11082311

Russo, Giulia, Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, and Edoardo Spina. 2023. "Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database" Biomedicines 11, no. 8: 2311. https://doi.org/10.3390/biomedicines11082311

Russo, G., Barbieri, M. A., Sorbara, E. E., Cicala, G., Franchina, T., Santarpia, M., Silvestris, N., & Spina, E. (2023). Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database. Biomedicines, 11(8), 2311. https://doi.org/10.3390/biomedicines11082311